Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
ASCO Breakthrough 2026
ASCO 2026
ESTRO 2026
AACR 2026
EBCC15
Calendar
View All
Topics
AI in Oncology
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
NCCN Hematologic Congress,NCCN Hematologic Congress
«
1
»
Advertisement
Advertisement
Jul
28
Today In Oncology
FDA Releases Final Guidances to Expand Participation in Cancer Clinical Trials
Phase III Trial Finds No Benefit for Magrolimab Combination in Higher-Risk MDS
ELEVATE Trial Shows Disease-Free Survival Benefit With Adjuvant Ensartinib in ALK-Positive NSCLC
Dabrafenib Plus Trametinib Improves Progression-Free Survival in BRAF V600E-Positive Differentiated Thyroid Cancer
Relapsed or Refractory Multiple Myeloma: Early-Phase Trial Investigates Novel Bispecific Antibody
View More
Advertisement
